What is the role of interferons in the treatment of renal cell carcinoma (RCC)?

Updated: Feb 19, 2021
  • Author: Kush Sachdeva, MD; Chief Editor: E Jason Abel, MD  more...
  • Print

Interferons have been largely replaced by single-agent molecular targeted therapy. Single-agent interferon therapy is generally no longer used. Currently, the only established role for these agents is the use of interferon alfa in combination with bevacizumab as first- or second-line therapy for metastatic renal cell carcinoma.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!